Quick Answer
Biomea Fusion, Inc. reported Net Income of -$61.80 million for fiscal year 2025.
Biomea Fusion, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$61.80M +55.4% |
-$138.43M -18.1% |
-$117.25M -43.3% |
-$81.83M -96.9% |
-$41.57M -680.7% |
-$5.32M -344.4% |
| Diluted EPS | -$1.18 +69.2% |
-$3.83 -11.3% |
-$3.44 -22.9% |
-$2.80 -60.9% |
-$1.74 -241.2% |
-$0.51 |
| Total Assets | $58.57M -26.7% |
$79.94M -60.0% |
$199.93M +54.6% |
$129.31M -30.4% |
$185.71M +197.0% |
$62.53M |
| Cash and Equivalents | $55.81M -4.2% |
$58.28M -67.0% |
$176.87M +58.1% |
$111.90M -23.2% |
$145.74M +136.2% |
$61.70M +25713.8% |
| Stockholders Equity | $29.55M -42.7% |
$51.57M -69.5% |
$169.24M +55.9% |
$108.54M -39.3% |
$178.78M +3358.8% |
$5.17M +24714.3% |
| R&D Expense | $61.98M -47.5% |
$118.08M +15.2% |
$102.55M +63.5% |
$62.71M +124.0% |
$28.00M +662.6% |
$3.67M +236.2% |
| Operating Income | -$83.51M +42.0% |
-$144.07M -14.2% |
-$126.14M -50.8% |
-$83.63M -100.7% |
-$41.67M -682.2% |
-$5.33M -345.8% |
| Shares Outstanding | 72.30M +99.1% |
36.31M +1.2% |
35.87M +21.3% |
29.56M +1.5% |
29.12M +143.6% |
11.95M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$16.41M | +50.0% | +20.9% |
| Diluted EPS | September 30, 2025 | -$0.27 | +70.3% | +47.1% |
| Total Assets | September 30, 2025 | $55.19M | -50.0% | -24.6% |
| Cash and Equivalents | September 30, 2025 | $46.64M | -47.0% | -17.0% |
| Stockholders Equity | September 30, 2025 | $15.62M | -79.4% | -43.2% |
| R&D Expense | September 30, 2025 | $14.40M | -47.1% | -13.1% |
| Operating Income | September 30, 2025 | -$20.80M | +38.9% | +2.2% |
| Shares Outstanding | September 30, 2025 | 59.51M | +64.2% | +2.4% |
- Biomea Fusion, Inc. reported Net Income of -$61.80 million for fiscal year 2025.
- Biomea Fusion, Inc. showed an increase of +55.4% in Net Income compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Diluted EPS of $1.18 per share (loss) for fiscal year 2025.
- Biomea Fusion, Inc. showed an increase of +69.2% in Diluted EPS compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Total Assets of $58.57 million for fiscal year 2025.
- Biomea Fusion, Inc. showed a decrease of -26.7% in Total Assets compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Cash and Equivalents of $55.81 million for fiscal year 2025.
- Biomea Fusion, Inc. showed a decrease of -4.2% in Cash and Equivalents compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Stockholders Equity of $29.55 million for fiscal year 2025.
- Biomea Fusion, Inc. showed a decrease of -42.7% in Stockholders Equity compared to the prior fiscal year.
- Biomea Fusion, Inc. reported R&D Expense of $61.98 million for fiscal year 2025.
- Biomea Fusion, Inc. showed a decrease of -47.5% in R&D Expense compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Operating Income of -$83.51 million for fiscal year 2025.
- Biomea Fusion, Inc. showed an increase of +42.0% in Operating Income compared to the prior fiscal year.
- Biomea Fusion, Inc. reported Shares Outstanding of 72.30 million shares for fiscal year 2025.
- Biomea Fusion, Inc. showed an increase of +99.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: